Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics

Fritschi, C. J., Liang, S., Mohammadi, M., Anang, S., Moraca, F., Chen, J., Madani, N., Sodroski, J. G., Abrams, C. F., Hendrickson, W. A., & Smith, A. B. (2021). Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics. ACS Medicinal Chemistry Letters, 12(11), 1824–1831. https://doi.org/10.1021/acsmedchemlett.1c00437
Authors:
Christopher J Fritschi
Shuaiyi Liang
Mohammadjavad Mohammadi
Saumya Anang
Francesca Moraca
Junhua Chen
Navid Madani
Joseph G Sodroski
Cameron F Abrams
Wayne A Hendrickson
Amos B Smith
Affiliated Authors:
Shuaiyi Liang
Wayne A Hendrickson
Author Keywords:
hiv
gp120
cd4
entry inhibitor
structure-based drug design
x-ray crystallography
viral inhibition
protein-protein interactions
Publication Type:
Article
Unique ID:
10.1021/acsmedchemlett.1c00437
PMID:
Publication Date:
Data Source:
PubMed

Record Created: